Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Combination of Metformin and Magnesium Citrate Reduces TNF-α, NF-κB p65, IL-6, CD4, and MMP-9 Expressions in Diabetic Model Rats

The Indonesian Biomedical Journal · Vol. 16 No. 6 (2024) · hlm. 546–552

DOI
10.18585/inabj.v16i6.3360
ISSN
2085-3297, 2355-9179
Terbit
2024-12-23
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Diabetes, which causes various complications, involves pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), nuclear factor kappa B p65 (NF-κB p65), interleukin-6 (IL-6), cluster of differentiation 4 (CD4), and matrix metalloproteinase-9 (MMP-9). Magnesium has demonstrated anti-diabetic properties, but its anti-inflammatory effects in preventing cardiovascular complications remain unclear. This study aimed to evaluate the anti-inflammatory effects of magnesium citrate, alone and in combination with metformin, by measuring TNF-α, NF-κB p65, IL-6, CD4, and MMP-9 expression in diabetic model rats.METHODS: Thirty male Wistar rats were divided into five groups: normal control, diabetes control, metformin (treated with 9 mg/200 g/day metformin), magnesium citrate (treated with 3.6 mg/200 g/day magnesium citrate), and combination therapy (treated with 4.5 mg/200 g/day metformin + 1.8 mg/200 g/day magnesium citrate). Diabetes was induced in all groups except the normal control group using streptozotocin (STZ) and nicotinamide (NA). TNF-α, NF-κB p65, IL-6, CD4, and MMP-9 expression levels were measured using enzyme-linked immunosorbent assay (ELISA).RESULTS: Significant differences in TNF-α, NF-κB p65, IL-6, CD4, and MMP-9 expression levels were observed across all groups (p<0.001). The combination therapy group demonstrated the most significant reduction in all parameters compared to the diabetic control group (p<0.001) and other therapy groups. Both metformin and magnesium citrate monotherapies showed moderate reductions in cytokine levels but were less effective than combination therapy.CONCLUSION: Combination therapy with metformin and magnesium citrate exhibited the most potent anti-inflammatory effects, significantly reducing TNF-α, NF-κB p65, IL-6, CD4, and MMP-9 expressions in diabetic Wistar rats. This combination has potential as a therapeutic approach for managing diabetes and its complications.KEYWORDS: diabetes mellitus, inflammation, cytokines, metformin, magnesium citrate

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 113 tautan kepenulisan bersama · 26 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Sebelas Maret University
  • State University of Semarang
  • Universitas Airlangga
  • Universitas Gadjah Mada
  • Syarif Hidayatullah State Islamic University Jakarta
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Ari Natalia ProbandariSebelas Maret University4
Brian WasitaSebelas Maret University3
Lilia Faridatul FauziahSebelas Maret University2
Diffah HanimSebelas Maret University2
Kuntoro KuntoroUniversitas Airlangga2
Retno Pudji RahayuUniversitas Airlangga2
Mandojo RukmoUniversitas Airlangga2
Suhartono Taat PutraUniversitas Airlangga2
Ambar MudigdoSebelas Maret University2
Elyana AsnarUniversitas Airlangga2
Ni Nyoman Tri PuspaningsihUniversitas Airlangga2
Harjanto HarjantoUniversitas Airlangga2
Joko Agus PurwantoUniversitas Airlangga2
Tonang Dwi ArdyantoSebelas Maret University2
Ema Nur FitrianaSebelas Maret University2
Rizky Amalia PuspitaningrumSebelas Maret University2
Ratih Tri Kusuma DewiSebelas Maret University2
Vitri WidyaningsihSebelas Maret University2
FarukAfiliasi tidak diketahui1
Achmad MunjidUniversitas Gadjah Mada1
Sri MulyaniSebelas Maret University1
Fatiah Handayani HandayaniSebelas Maret University1
Endang Sutisna SulaemanSebelas Maret University1
Fatma HetamiState University of Semarang1
Rohaeni RohaeniState University of Semarang1
Maria Johana Ari WidayantiState University of Semarang1
Yosia Puri SaputroState University of Semarang1
Mohamad Ikhwan RosyidiState University of Semarang1
Hanna Eka RositaState University of Semarang1
Nur Lailiyatul InayahSyarif Hidayatullah State Islamic University Jakarta1
Rudi HartonoState University of Semarang1
Wayan AnggunturState University of Semarang1
Julhan IrfandiSebelas Maret University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Combination of Metformin and Magnesium Citrate Reduces TNF-α, NF-κB p65, IL-6, CD4, and MMP-9 Expressions in Diabetic Model Rats</dc:title><dc:creator>Rachmi Fauziah Rahayu</dc:creator><dc:creator>Adi Prayitno</dc:creator><dc:creator>Bambang Purwanto</dc:creator><dc:creator>Widiastuti Soewondo</dc:creator><dc:creator>Ida Nurwati</dc:creator><dc:creator>Eti Poncorini Pamungkasari</dc:creator><dc:creator>Paramasari Dirgahayu</dc:creator><dc:subject>metformin</dc:subject><dc:subject>magnesium citrate</dc:subject><dc:subject>combination therapy</dc:subject><dc:subject>diabetes mellitus</dc:subject><dc:subject>inflammation</dc:subject><dc:subject>TNF-α</dc:subject><dc:subject>NF-κB p65</dc:subject><dc:subject>interleukin-6</dc:subject><dc:subject>CD4</dc:subject><dc:subject>MMP-9</dc:subject><dc:subject>streptozotocin-nicotinamide-induced diabetes</dc:subject><dc:subject>anti-inflammatory activity</dc:subject><dc:subject>diabetes complications</dc:subject><dc:subject>cardiovascular complications</dc:subject><dc:subject>cytokines</dc:subject><dc:subject>rats</dc:subject><dc:subject>Wistar rats</dc:subject><dc:description xml:lang="en">BACKGROUND: Diabetes, which causes various complications, involves pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), nuclear factor kappa B p65 (NF-κB p65), interleukin-6 (IL-6), cluster of differentiation 4 (CD4), and matrix metalloproteinase-9 (MMP-9). Magnesium has demonstrated anti-diabetic properties, but its anti-inflammatory effects in preventing cardiovascular complications remain unclear. This study aimed to evaluate the anti-inflammatory effects of magnesium citrate, alone and in combination with metformin, by measuring TNF-α, NF-κB p65, IL-6, CD4, and MMP-9 expression in diabetic model rats.METHODS: Thirty male Wistar rats were divided into five groups: normal control, diabetes control, metformin (treated with 9 mg/200 g/day metformin), magnesium citrate (treated with 3.6 mg/200 g/day magnesium citrate), and combination therapy (treated with 4.5 mg/200 g/day metformin + 1.8 mg/200 g/day magnesium citrate). Diabetes was induced in all groups except the normal control group using streptozotocin (STZ) and nicotinamide (NA). TNF-α, NF-κB p65, IL-6, CD4, and MMP-9 expression levels were measured using enzyme-linked immunosorbent assay (ELISA).RESULTS: Significant differences in TNF-α, NF-κB p65, IL-6, CD4, and MMP-9 expression levels were observed across all groups (p&lt;0.001). The combination therapy group demonstrated the most significant reduction in all parameters compared to the diabetic control group (p&lt;0.001) and other therapy groups. Both metformin and magnesium citrate monotherapies showed moderate reductions in cytokine levels but were less effective than combination therapy.CONCLUSION: Combination therapy with metformin and magnesium citrate exhibited the most potent anti-inflammatory effects, significantly reducing TNF-α, NF-κB p65, IL-6, CD4, and MMP-9 expressions in diabetic Wistar rats. This combination has potential as a therapeutic approach for managing diabetes and its complications.KEYWORDS: diabetes mellitus, inflammation, cytokines, metformin, magnesium citrate</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2024-12-23</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v16i6.3360</dc:identifier><dc:identifier>10.18585/inabj.v16i6.3360</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 16 No 6 (2024); 546-552</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/3360/746</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>